A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Conditions
Multiple Myeloma · Myeloma · Myeloma Multiple
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic, San Francisco, California, United States
Contact: Principal Investigator (Alfred Chung, MD)Mayo Clinic Hospital - Florida, Jacksonville, Florida, United States
Contact: Principal Investigator (Vivek Roy, MD)The Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Sagar Lonial, MD, FACP)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Andrew Yee, MD)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Yuxin Liu, MD)Mayo Clinic - Transplant Center - Rochester, Rochester, Minnesota, United States
Contact: Principal Investigator (David Dingli, MD, PhD)Hackensack University Medical Center, Hackensack, New Jersey, United States
Contact: Principal Investigator (David S Siegel, MD, PhD)Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Saad Usmani, MD, FACP)Atrium Health, Levine Cancer Institute, Charlotte, North Carolina, United States
Contact: Principal Investigator (Cindy Varga, MD)Duke University Hospital, Durham, North Carolina, United States
Contact: Principal Investigator (Cristina Gasparetto, MD)University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Ed Stadtmauer, MD)Tennessee Oncology, Nashville, Tennessee, United States
Contact: Principal Investigator (Jesus Berdeja, MD)University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas, United States
Contact: Principal Investigator (Aimaz Afrough, MD)University Health Network (UHN) - Princess Margaret Cancer Centre (Princess Margaret Hospital), Toronto, Ontario, Canada
Contact: Principal Investigator (Suzanne Trudel, MSc, MD)Universitaire de Lille, Villeneuve-d'Ascq, France, France
Contact: Principal Investigator (Salomon Manier, MD)Centre Hospitalier Universitaire de Nantes (CHU de Nantes) - Hotel-Dieu, Nantes, France
Contact: Study coordinator (Cyrille Touzeau, MD) · cyrille.touzeau@chu-nantes.fr · 33 (0) 2 40 08 32 71Contact: Principal Investigator (Cyrille Touzeau, MD)Centre Hospitalier Universitaire de Poitiers (CHU de Poitiers), Poitiers, France
Contact: Principal Investigator (Xavier Leleu, MD)Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
Contact: Principal Investigator (Pierre Bories, MD)Clínica Universidad de Navarra, Pamplona, Navarre, Spain
Contact: Principal Investigator (Paula Rodriguez, MD, PhD)Hospital ClÃ-nic de Barcelona, Barcelona, Spain
Contact: Principal Investigator (Laura Rosinol, MD, PhD)Hospital Universitario 12 de Octubre, Madrid, Spain
Contact: Study coordinator (Lucía Sánchez Pérez) · luciasanchez12imas@gmail.com · (+34) 91 779 28 09Contact: Principal Investigator (Joaquín Martínez López, MD)Instituto de Investigacion Biomedica de Salamanca (IBSAL), Salamanca, Spain
Contact: Principal Investigator (Maria-Victoria Mateos Manteca, MD, PhD)